Sign in

NCT07217366Enrolling by invitation

Speech-to-text Tool for Heart Failure Patient-Reported Data

Testing a Speech-to-text Tool for Heart Failure Patient-Reported Data

Source: ClinicalTrials.gov · Last updated 27 Mar 2026

Brief summary (registry, in English)

The goal of this study is to see whether this type of Artificial Intelligence (AI) Voice Assistant can reliably capture patient-reported health information to support communication between patients and their healthcare team.

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
100 (estimated)
First submitted
13 Oct 2025
Start date
13 Oct 2025
Primary completion date
31 May 2026
Lead sponsor
Stanford University
NCT number
NCT07217366

What you commit to

  • Study type: Interventional
  • Planned participants: 100
  • From 13 Oct 2025 to the primary completion date, 31 May 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Any disorder or condition that, in the opinion of the investigator would pose a risk to participant safety or interfere with the study evaluation, procedures or completion

Other

  • Diminished decision-making capacity
  • Inability to understand and communicate in English sufficiently to complete study procedures
  • Inability to complete study procedures to the best of the participant's and investigator's knowledge

Who the study is looking for

  • Adults with heart failure receiving cardiology care at Stanford University

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Stanford University
Coordinator of this site? Confirm its status
Palo AltoUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.